Bayer, AG
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Bayer, AG - overview
Established
1863
Location
-, -, Germany
Primary Industry
Chemicals
About
Bayer AG is a global leader in agriculture, focusing on providing innovative crop protection, seeds, and digital farming solutions that enhance productivity and sustainability for farmers worldwide. Bayer AG operates in the agricultural sector, offering solutions for crop production and management. Founded in 1863 in Germany, the company has evolved over time and currently operates out of Leverkusen, Germany. The CEO of Bayer AG is Helge Reimelt, who leads the company in its mission to address agricultural challenges.
Bayer Crop Science is a prominent player in the global agricultural sector, providing a wide array of innovative solutions to enhance crop production and sustainability. The company's core product offerings include advanced crop protection solutions, seeds and traits, and digital farming technologies that empower farmers to optimize their agricultural practices while minimizing resource use. These products address critical challenges such as pest management, disease control, and soil health, ultimately aiming to increase agricultural productivity sustainably. Bayer's clientele spans across various geographical markets including North America, Europe, and Latin America, serving a diverse range of end users, from large-scale commercial farmers to smallholder farmers.
The company's commitment to regenerative agriculture reflects its dedication to producing more food while restoring natural ecosystems, thereby catering to the growing global demand for sustainable agricultural practices. Bayer Crop Science generates revenue through multiple channels, including direct sales of agricultural products to farmers, partnerships with distributors, and collaborations with retailers. The company's transactions typically involve the sale of proprietary products such as herbicides, fungicides, and genetically engineered seeds, which are marketed through both business-to-business (B2B) and direct-to-consumer (D2C) models. Farmers can access Bayer's crop protection solutions and genetically modified seeds through authorized retailers and agricultural co-ops, often under structured agreements that facilitate bulk purchasing and support services.
While specific pricing details are proprietary, Bayer’s flagship products are positioned to provide significant value to farmers, enabling them to achieve higher yields and improved crop resilience in an increasingly challenging climate. This multifaceted revenue model supports Bayer's overarching goal of sustainable agricultural advancement while ensuring a steady income stream from its diverse product portfolio.
Primary Industry
Chemicals
Sub Industries
Bioinformatics, Pharmaceutical Research & Development, Green IT, Scientific Software, Agricultural Chemicals
Website
http://www.bayercropscience.com
Verticals
Agtech, Research (Non-Medical)
Total Amount Raised
Subscriber access only
Bayer, AG - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Buyout | Completed | Briar Chemicals Limited | - |
Displaying 1 - 1 of 1

Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.